Intraoperative use of dexmedetomidine is associated with decreased overall survival after lung cancer surgery

Intraoperative use of dexmedetomidine is associated with decreased overall survival after lung cancer surgery

Background and Aims: The aim is to evaluate the association between the use of intraoperative dexmedetomidine with an increase in recurrence-free survival (RFS) and overall survival (OS) after nonsmall cell lung cancer (NSCLC) surgery. Material and Methods: This was a propensity score-matched (PSM)...

Full description

Bibliographic Details
Main Authors: Juan P Cata, Vinny Singh, Brenda M Lee, John Villarreal, John R Mehran, J Yu, Vijaya Gottumukkala, Hagar Lavon, Shamgar Ben-Eliyahu
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Journal of Anaesthesiology Clinical Pharmacology
Subjects:
Dexmedetomidine
lung cancer
surgery
Online Access:http://www.joacp.org/article.asp?issn=0970-9185;year=2017;volume=33;issue=3;spage=317;epage=323;aulast=Cata

Internet

http://www.joacp.org/article.asp?issn=0970-9185;year=2017;volume=33;issue=3;spage=317;epage=323;aulast=Cata

Similar Items